Skip to main content

Dawood TAGHIZADEH (01043)

Nature of action taken:

On March 22, 2024, pursuant to s. 39(1)(c) of the Health Professions Act, RSBC 1996, c. 183 (the “HPA”), the Discipline Committee Panel determined that Mr. Dawood Taghizadeh engaged in professional misconduct by:

  1. on various dates between January and December 2022, engaging in the unauthorized use of the title Doctor and Dr. on two publicly accessible websites, Twitter and Facebook, contrary to sections 12(2)(b) and 12.1 of the HPA, section 3 of the Regulation and section 92(2) of the College’s Bylaws;
  2. engaging in the unauthorized use of the title Doctor and Dr. in marketing materials that were made available at Mr. Taghizadeh’s clinic in April 2022, including a business card and a pamphlet, contrary to sections 12(2)(b) and 12.1 of the HPA, section 3 of the Regulation and section 92(2) of the College’s Bylaws;
  3. on various dates between January and December 2022, engaging in misleading marketing practices by using the word “medical” on the Facebook page associated with his Clinic, contrary to section 92(2) of the College’s Bylaws; and
  4. engaging in misleading marketing practices by using the term “medical” in his clinic marketing materials, including a business card and a pamphlet that were made available at his clinic in April 2022.

The Panel set a schedule for written submissions on penalty and costs.

Reason for Action:

The Panel was satisfied that the Respondent committed professional misconduct by engaging in the unauthorized use of the title Doctor and Dr. on two publicly accessible websites, engaging in the unauthorized use of the title Doctor and Dr. in his marketing materials, engaging in misleading marketing practices by using the word “medical” on the Facebook page associated with his clinic, and engaging in misleading marketing practices by using the word “medical” in his clinic marketing materials.